Treatment of Bipolar disorder
|
|
- Hester Allyson Allison
- 5 years ago
- Views:
Transcription
1 8/6/215 Treatment of Bipolar disorder Pichai Ittasakul, M.D. Department of Psychiatry, Ramathibodi Hospital, Mahidol University Bipolar disorder Manic-depressive Illness. is characterized by the occurrence of at least one manic or mixed-manic episode. Most patients also have one or more depressive episodes at other times. Bipolar disorder is multisystemic Mood & affect instability Medical burden Circadian rhythm instability Cognition & executive functioning 1
2 Hazard Ratio for mortality 8/6/215 Comorbidity and Mortality in bipolar disorder 12 Women Men Suicide Influenza DM COPD Stroke CVD IHD Cancer Crump C et al. JAMA psychiatry. 213 Sep 1;7(9): Classification of bipolar disorder Unipolar depression Bipolar I Bipolar II Cyclothymia Bipolar NOS Depressive episodes Manic and depressive episodes Hypomanic, depressive episodes Hypomania, subthreshold depression Subthreshold hypomania, subthreshold depression From DSM IV-TR to DSM V Criterion A for manic and hypomanic episode : includes an emphasis on changes in activity and energy as well as mood Bipolar I disorder, mixed episode has been removed. A new specifier, with mixed features, has been added. Anxious distress specifier is delineated. 2
3 8/6/215 The presence of manic/hypomanic symptoms in patients with recurrent unipolar depression Cassano et al. Am J psychiatry 24 Mixed mania vs mania More prior mixed episodes 3,8 Less congruent psychotic features 1-8 More suicidal risk 8 Less inter-episodic remission 3 (residual symptomatology) 1. Dell Osso et al. 1993; 2. Perugi et al. 1997; 3. Akiskal et al. 1998; 4. Himmelhoch et al. 1976; 5. Dilsaver et al. 1993; 6. Strakowski et al. 1996; 7. Goldberg et al. 1998; 8. Perugi et al
4 Prevalence of suicidality 8/6/215 Mixed mania is associated with a higher risk of suicide % 57.9% 1.3% 63/184 (1/77) 62/17 All pure mania mixed mania Goldberg et al. Am J psychiatry 1998 Treatment of Bipolar disorder Treatment Pharmacotherapy Psychosocial intervention Mood stabilizer Anticonvulsants Antipsychotic Psychoeducation Interpersonal and social rhythm therapy CBT Family intervention 4
5 8/6/215 Treatment aims Achieve functional recovery, not just treat or control mood episodes Improve physical health Reduce stigma and social exclusion Address subthreshold symptoms and their drivers Augment personal autonomy, and well-being to improve quality of life Strategy and time course Acute Continuation Maintenance -8 wks Syndromal Recovery Maximize mood stabilizers; adjunctive treatment Support/structure; Education; involve family 1-6 months Functional Recovery Optimize tolerability; Taper adjunctive Medications when Possible Cognitive behavioral systems; Indefinite Maximize function; Stability Optimize efficacy And tolerability; Anticipate prodromes Strategies to Optimize adaptation And remission Pharmacotherapy Bipolar disorder pharmacotherapy depends on Illness Subtypes Phase Clinical features 5
6 8/6/215 Pharmacological treatment targets Neurotransmitter/ Neurohormonal dysreguration Intracellular signaling Neural mechanism Dopamine, Serotonin, Glutamate Inosital monophosphatese, GSK3, PKC, Calcium channels Corticolimbic emotion control circircuit Sleep and circardian regulation Circadian clock associated with impaired sleep and weight changes US FDA-approved treatments for Bipolar disorder Acute Mania Acute Depression Long-term treatment Year Drug Year Drug Year Drug 197 Lithium 1973 Chlorpromazine 1994 Divalproex 2 Olanzapine* 23 Risperidone* 24 Quetiapine* 24 Ziprosidone 24 Aripiprazole* 24 Carbamazepine 29 Asenapine* OLZ + fluoxetine Quetipine, XR (28) Lurasidone Unmet need Lithium Lamotrigine Olanzapine Aripiprazole Quetiapine, XR(adjunct) Risperidone LAI* Ziprasidone Unmet need * Adjunctive and monotherapy Treatment of mania Lithium, Chloropromanize Antiepileptics Second-generation antipsychotics Differences in both efficacy and tolerability between agents Antipsychotic drugs seem to be better than lithium and anticonvulsants Olanzapine, risperidone and haloperidol seem to have the best profile of available agent Cipriani A. et al., Lancet. 211;378:
7 Percent Responders ( 5% mania rating decrease) Percent responders ( 5% mania rating decrease) 8/6/215 Overview of 22 Acute Mania Registration Studies Monotherapy Studies 49.9% 2.% 5 Combination Therapy Studies NNT 5 6 Monotherapy vs Combination vs Monotherapy 59.4% 18.1% 41.3% % 1 p <.1. N = 2258 Li/DVPX/CBZ/SGA N = 1798 N = 862 SGA + Li/DVPX N = 646 Li/DVPX Ketter Montherapy TA (ed). vs. Handbook, of Combination Diagnosis and therapy Treatment vs. of Monotherapy Bipolar Disorder, increase Am Psych Response Pub, Inc., Rate Washington, approximately DC, 21. 2%. Acute Mania Monotherapy Registration Studies NNT Somnolence / Sedation NNH Weight Gain NNH ? N=134 N=261 N=223 N=124 N=434 N=357 N=268 N=26 N=357 Lithium Divalproex Carbamazepine Olanzapine Risperidone Quetiapine Ziprasidone Aripiprazole Asenapine Adapted from: Ketter TA (ed). Handbook Weight of Diagnosis gain > Somnolence and Treatment of / Bipolar Sedation Disorder, > Antimanic Am Psych Pub, variability. Inc., Washington, DC, 21. N=1938 (pooled) Treatment of bipolar depression Is a major challenge, with few treatment options. 7
8 Percentage of patients 8/6/215 Time Spent Depressed (12.8 yr follow up) Mixed/rapid cycling 5.9% Mixed/rapid cycling 2.3% Asymptomatic 52.9% Depressed 31.9% Manic 8.9% Asymptomatic 46.1% Depressed 5.3% Hypomanic 1.3% Bipolar I Bipolar II (n = 146) (n = 86) Judd LL et al. Arch Gen Psychiatry 22;59(6): Judd LL et al. Arch Gen Psychiatry. 23;6(3) Misdiagnosis of Bipolar Disorder 25 MDD patients MINI 6 patients were diagnosed BP 19 (7.6%) BP I 41 (16.4%) BP II Waleeprakhon et al. 214 Meta-analysis of antidepressant in acute bipolar depression Response/Remission rates 41.% Antidepressant 38.2% N=41 N=68 7.7% 7.2% Antidepressant Switching rate NNT 36 NNH 2 Sador MM, Macqueen GM, J Clin Psychiatry 211 Feb;72(2):
9 Percent Responders ( 5% depression rating decrease) 8/6/215 Correlates of antidepressant: related switching into hypomania/mania Younger age Bipolar I > Bipolar II subtype Rapid cycling (> 4 episodes) in the past year Mixed depression TCAs > second-generation antidepression Norepinephrine active > serotonin or dopamine Substance abuse history If not antidepressant Single or combinations of conventional mood stabilizers* Lamotrigine*, Lithium* Second generation antipsychotic : olanzapine+fluoxetine : quetiapine : lurasidone Other pharmacotherapies* Psychotherapy * not approved by US FDA for acute bipolar depression Overview of Acute Bipolar Depression Studies NNT Approved Treatments Unapproved Treatments % 3% 59% 4% ** 47% * 39% 38% 3% OFC PBO QTP PBO OLZ PBO LTG PBO Tohen 3 Calabrese 5, Thase 6 Tohen 3 Geddes 9 = N * p <.5, ** p <.1, p <.1 vs. PBO. 9
10 Percentage with relapse 8/6/215 US FDA-approved treatments for Bipolar disorder Acute Mania Acute Depression Long-term treatment Year Drug Year Drug Year Drug 197 Lithium 1973 Chlorpromazine 1994 Divalproex 2 Olanzapine* 23 Risperidone* 24 Quetiapine* 24 Ziprosidone 24 Aripiprazole* 24 Carbamazepine 29 Asenapine* OLZ + fluoxetine Quetipine, XR (28) Lurasidone Unmet need Lithium Lamotrigine Olanzapine Aripiprazole Quetiapine, XR(adjunct) Risperidone LAI* Ziprasidone Unmet need * Adjunctive and monotherapy Long-term maintenance treatment Lithium is an efficacious treatment, however, the benefits of lithium are restricted by adverse effects and low therapeutic effects. Divalproex, although not approved for bipolar maintenance monotherapy, is commonly used as monotherapy or adjunctive therapy. NNT % 6.6% Lithium (n = 369) (n = 41) 32.3% 25.% 13.8% 23.6% Overall relapse Depressive relapse Hypo/manic relapse Summary form 5 double-blind lithium monotherapy VS placebo maintenance trails from 1973 and 23. ** p <.1 (Geddes et al. 24) 1
11 8/6/215 LiTMUS study Lamotrigine maintenance study Lamotrigine and lithium were superior to placebo in time to intervention for any mood episode Larmotrigine was superior to placebo for time to intervention for depression Mean LTG dose was 245 ay, mean serum LI level was.7 meq/l Goodwin et al
12 Percent Relapse/Recurrence 8/6/215 Overview of Bipolar Monotherapy Maintenance Studies NNT Lamotrigine vs * 61% 11% 5% Lithium vs 16% 45% Olanzapine vs *** 33% 47% 8% Aripiprazole vs * 19% 25% 43% Risperidone vs 56% 26% 3% Quetiapine Lithium vs vs Quetiapine unapproved for maintenance monotherapy 52% 29% 26% 26% 23% LTG PBO Li OLZ PBO ARI PBO RSP PBO QTP PBO Li Goodwin 4 Tohen 6 Keck 6 Quiroz 1 Weisler 9 * p <.5, *** p <.1, p <.1 vs. PBO. Ketter TA (ed). Handbook Approved of Diagnosis maintenance and Treatment treatments of Bipolar Disorder, have Am single-digit Psych Pub, Inc., NNTs. Washington, DC, 21. = N Atypical Antipsychotics: Summary of Long-Term Data Adjunct or Monotherapy Index Episode Any mood event = at least 1 randomized controlled trial (RCT) showing significant effects = at least 1 RCT showing some effect = adequately powered, RCT evidence of a lack of significant effects? = inadequately powered, uncertain, or no controlled data available Delay of Episode Recurrence Mania/Mixed Depression Olanzapine M Mania/Mixed Risperidone Quetiapine A and M A and M Mania/Mixed/ Remission Mania/Mixed/ Depression Ziprasidone A Mania/Mixed? Aripiprazole M Mania/Mixed? Asenapine M Mania/Mixed? Paliperidone - -??? Tohen et al, 23b; Tohen et al, 26; Keck et al, 27; Vieta et al, 28b; Vieta et al, 28c; Young et al, 28a; McElroy et al, 28; Weisler et al, 28; Suppes et al, 29; Vieta et al, 29.?? Recommendations on antidepressants use in bipolar disorder 1th International Conference on Bipolar Disorders (ICBD), Miami, USA. the result of a review of 173 studies to assess the quality of the evidence for antidepressant use in bipolar depression. 12
13 8/6/215 Should be avoided Antidepressant Monotherapy - Adjunctive treatment with SNRI and TCA be considered only after other antidepressants have been tried. Acute depressive episode Mood Stabilizer 1th International Conference on Bipolar Disorders (ICBD). Maintenance treatment Mood Stabilizer Antidepressant Antidepressant may be considered if a patient relapses into a depressive episode after stopping antidepressant therapy. 1th International Conference on Bipolar Disorders (ICBD). 13
14 Percentage Recovered 8/6/215 Antidepressant use in mixed states Should be avoided during manic and depressive episodes with mixed features. bipolar patients with predominantly mixed states. Previously prescribed antidepressants should be discontinued in patients experiencing current mixed states. Psychosocial treatment targets Responses to stressful event High expressed emotion and negative family interactions Sleep and circadian regulation Drug Adherence STEP-BD Randomized Bipolar Depression Studies NNT *p <.5 6 Bupropion - 3 (N = 86) * 64.4% 4 Paroxetine - 3 (N = 93) 51.5% % 27.3% Mood Stabilizer Mood Stabilizer + Antidepressant = N Intensive Brief Psychotherapy Psychoeducation Sachs GS, et al. N Engl J Med 27;356: Miklowitz DJ, et al. Arch Gen Psychiatry 27;64:
15 8/6/215 Adjunctive Psychosocial therapy: NNT for Relapse/Recurrence prevention Psychoeducation Nonstructured therapy N Relapse/ Recurrence Rate% NNT VS comparator Sample, Source After 6+ months of remission Colom 23 Family focused therapy After acute episode. Crisis management Miklowitz 23 Cognitive therapy When euthymic/ No psychotherapy subsyndromal 23 Conclusion Treatment of bipolar disorder focuses on acute stabilization and on maintenance. Balancing between efficacy and tolerability needs to be considered for treatment options. Important unmet needs - well-tolerated treatments for acute depression and maintenance Efficacy of treatment can be enhanced by the combination of psychosocial treatment with drugs. 15
PDF created with pdffactory Pro trial version
با ی د ر ا ر وه روا ز ش ی دا ه ع وم ش ی ا ان Treatment Challenges in BD Major depressive episode Mixed states= 20% Rapid cycling= 18% (annually), 31.5% (lifetime) Psychiatric Comorbidity (substance abuse,
More informationManagement of Bipolar Depression
Management of Bipolar Depression Haresh M. Tharwani, M.D. Associate Clinical Professor Medical Director-DRH & Duke Psychiatry Specialty Clinic of Cary, N.C. Bipolar Disorders (Manic-Depressive illness)
More informationThe Pharmacological Management of Bipolar Disorder: An Update
Psychobiology Research Group The Pharmacological Management of Bipolar Disorder: An Update R. Hamish McAllister-Williams, MD, PhD, FRCPsych Reader in Clinical Psychopharmacology Newcastle University Hon.
More informationOverview Treatment-Resistant Bipolar Disorder. Management of Bipolar Disorder When First-Line Interventions Fail Practical Tips
Overview Management of Bipolar Disorder When Interventions Fail Practical Tips Terence A. Ketter, MD Professor of Psychiatry and Behavioral Sciences Stanford University School of Medicine Stanford, California
More informationYour footnote
MANIA Your footnote Your footnote Cipriani A, Barbui C, Salanti G et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. The Lancet 2011;
More informationImproving the Recognition and Treatment of Bipolar Depression
Handout for the Neuroscience Education Institute (NEI) online activity: Improving the Recognition and Treatment of Bipolar Depression Learning Objectives Apply evidence-based tools that aid in differentiating
More informationChallenges in identifying and treating bipolar depression: a guide
Challenges in identifying and treating bipolar depression: a guide Dr. Paul Stokes Clinical Senior Lecturer, Centre for Affective Disorders, Department of Psychological Medicine Overview Challenges in
More informationWhat s new in the treatment of bipolar disorder?
What s new in the treatment of bipolar disorder? Dr. David Cousins MRC Clinician Scientist Institute of Neuroscience Newcastle University NCMD 2017 What s new in the treatment of bipolar disorder? Dr.
More informationCHAIR SUMMIT 7TH ANNUAL #CHAIR2014. Master Class for Neuroscience Professional Development. September 11 13, Westin Tampa Harbour Island
#CHAIR2014 7TH ANNUAL CHAIR SUMMIT Master Class for Neuroscience Professional Development September 11 13, 2014 Westin Tampa Harbour Island Sponsored by #CHAIR2014 Bipolar Depression: Putting the End Goal
More informationClinical Guideline for the Management of Bipolar Disorder in Adults
Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:
More informationSolving Clinical Challenges in Bipolar Disorder
Overview Bipolar Disorder Solving Clinical Challenges Solving Clinical Challenges in Bipolar Disorder Terence A. Ketter, MD Professor Emeritus Department of Psychiatry and Behavioral Sciences Stanford
More informationPsychiatry Clinical Reviews Treating Bipolar Depression
Mayo School of Continuous Professional Development Psychiatry Clinical Reviews Treating Bipolar Depression Mark A. Frye, MD October 6-8, 2016 Intercontinental Chicago Magnificent Mile Chicago, IL 2015
More informationBipolar Depression: Engaging the Patient. Mark Frye, MD Mayo Clinic Rochester, MN
Bipolar Depression: Engaging the Patient Mark Frye, MD Mayo Clinic Rochester, MN Mark Frye, MD Disclosures Research/Grants: AssureRX Health Inc.; Janssen Research & Development, LLC; Mayo Foundation for
More informationMultistate Outcome Analysis of Treatment MOAT
Multistate Outcome Analysis of Treatment MOAT Charles L. Bowden, M.D. Presented with Fond Memories of an Outstanding Statistician and Investigative Scientist Andy Leon Design contributors to low generalizability
More informationBIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences BIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD PROFESSOR DEPARTMENT OF PSYCHIATRY UNIVERSITY
More informationAntipsychotics in Bipolar
Use of Second-Generation Antipsychotics in Bipolar Disorder: A Practical Guide Flavio Guzman, MD Editor Psychopharmacology Institute This practical guide is an update on the use of second-generation antipsychotics
More informationEffectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials
International Journal of Neuropsychopharmacology (2011), 14, 1029 1049. f CINP 2011 doi:10.1017/s1461145711000885 Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder:
More informationKelly Godecke, MD Department of Psychiatry University of Utah
Kelly Godecke, MD Department of Psychiatry University of Utah Epidemiology and Impact -module 2 session 1 overview of mood disorders Diagnostic Criteria of Bipolar Disorders Medications Used in Bipolar
More informationPractical Guide to Long-Term Pharmacotherapy in Bipolar Disorder: An Updated Synthesis of Current Clinical Guidelines
SECOND-GENERATION ANTIPSYCHOTICS IN BIPOLAR DISORDER Practical Guide to Long-Term Pharmacotherapy in Bipolar Disorder: An Updated Synthesis of Current s Flavio Guzman, MD Editor Psychopharmacology Institute
More informationComprehensive Pharmacologic Management of Bipolar Depression Alexander McGirr, MD, MSc 1 David J. Bond, MD, PhD 2,*
Current Treatment Options in Psychiatry (2014) 1:263 277 DOI 10.1007/s40501-014-0017-2 Mood Disorders (AH Young, Section Editor) Comprehensive Pharmacologic Management of Bipolar Depression Alexander McGirr,
More informationFlorida Best Practice Medication Guidelines Principles of Practice for Adults
http://flmedicaidbh.fmhi.usf.edu Florida Best Practice Medication Guidelines Principles of Practice for Adults 1. Goal of the Guidelines Persistent gaps exist in the quality of mental health care delivered
More informationBipolar Disorder 4/6/2014. Bipolar Disorder. Symptoms of Depression. Mania. Depression
Bipolar Disorder J. H. Atkinson, M.D. Professor of Psychiatry HIV Neurobehavioral Research Programs University of California, San Diego KETHEA, Athens Slides courtesy of John Kelsoe, M.D. Bipolar Disorder
More informationIt's Cycling, Not Polarity Understanding and Diagnosing the Bipolar Spectrum
It's Cycling, Not Polarity Understanding and Diagnosing the Bipolar Spectrum Session 4022: American Psychiatric Nurses Association National Conference, Louisville, KY Andrew Penn, RN, MS, NP, CNS Psychiatric
More informationPractice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder,
Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Journal of the Academy of Child and Adolescent Psychiatry, 1997 Primary Authors: Jon McClellan MD
More informationBipolar Disorder in Youth
Bipolar Disorder in Youth Janet Wozniak, M.D. Associate Professor of Psychiatry Director, Pediatric Bipolar Disorder Research Program Harvard Medical School Massachusetts General Hospital Pediatric-Onset
More informationClass Update: Oral Antipsychotics
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationFixing the Mix-Up Over Mixed Depression
Handout for the Neuroscience Education Institute (NEI) online activity: Fixing the Mix-Up Over Mixed Depression Diagnosing and Treating DSM-5 Defined Mixed Features in Mood Disorders Learning Objectives
More information35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child
Stephen M. Strakowski, MD Chart Review: Bipolar Disorder PATIENT INFO 35 Age: Female Sex: 35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child Background: SI and hospitalization
More informationComparison of the Usefulness of Lithium and Valproate
Review Article CNPT4(2013) 1-5 Comparison of the Usefulness of Lithium and Valproate, M.D., Ph.D. Department of Neuropsychiatry, Oita University Faculty of Medicine ABSTRACT This review shows that lithium
More informationManaging Bipolar Depression and Mixed Episodes
Managing Bipolar Depression and Mixed Episodes Outline Diagnosing bipolar disorder with DSM-5 Treating mixed features of bipolar disorder Improving health outcomes in bipolar depression Role of psychosocial
More informationA systematic review of the evidence on the treatment of rapid cycling bipolar disorder
Bipolar Disorders 2013: 15: 115 137 Review Article Ó 2013 John Wiley and Sons A/S Published by Blackwell Publishing Ltd. BIPOLAR DISORDERS A systematic review of the evidence on the treatment of rapid
More informationPharmacotherapy of Bipolar Disorder Roger S. McIntyre, MD, FRCPC
Pharmacotherapy of Bipolar Disorder Roger S. McIntyre, MD, FRCPC Professor of Psychiatry and Pharmacology University of Toronto Head, Mood Disorders Psychopharmacology Unit University Health Network Toronto,
More informationSOMEWHERE OVER THE RAINBOW: RECOMMENDATIONS FOR THE DIAGNOSIS AND TREATMENT OF DEPRESSIVE MIXED STATES
SOMEWHERE OVER THE RAINBOW: RECOMMENDATIONS FOR THE DIAGNOSIS AND TREATMENT OF DEPRESSIVE MIXED STATES Learning Objectives Impart the importance of screening for the presence of mixed features and family
More information35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child
Stephen M. Strakowski, MD Chart Review: Bipolar Disorder PATIENT INFO 35 Age: Female Sex: 35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child Background: SI and hospitalization
More informationPsychiatry in Primary Care: What is the Role of Pharmacist?
Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure
More informationWhere to from Here? Evidence-Based Strategies for Treatment of Refractory Depression
Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression Michael D. Jibson, MD, PhD Professor of Psychiatry University of Michigan Major Depression #1 WHO cause of disability
More informationThe Challenge of Treatment in Bipolar Depression: Evidence from Clinical Guidelines, Treatment Recommendations and Complex Treatment Situations
53 The Challenge of Treatment in Bipolar Depression: Evidence from Clinical Guidelines, Treatment Recommendations and Complex Treatment Situations Authors S. Köhler 1, S. Gaus 1, T. Bschor 2, 3 Affiliations
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Single Technology Appraisal Aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar disorder in children and adolescents
More informationBipolar Disorders. Disclosure Statement. I have no financial disclosures or conflicts of interest
Bipolar Disorders Ahsan Naseem, MD Diplomate American Board of Psychiatry and Neurology Adult and Geriatric Psychiatry Medical Director Bryan Heartland Psychiatry Bryan Physician Network Partner Cheney
More informationMedication for Anxiety and Depression. PJ Cowen Department of Psychiatry, University of Oxford
Medication for Anxiety and Depression PJ Cowen Department of Psychiatry, University of Oxford Topics Medication for anxiety disorders Medication for first line depression treatment Medication for resistant
More informationBIPOLAR DISORDERS UPDATE. Anthony Archer, DO
BIPOLAR DISORDERS UPDATE Anthony Archer, DO OBJECTIVES Review the major developments and trends in diagnosis and management of bipolar disorders. Discuss and promote the role of the primary care physician
More informationLong-term Treatment in Bipolar Disorder: Fall 2015 Update
Long-term Treatment in Bipolar Disorder: Fall 2015 Update Roy H. Perlis, MD MSc Center for Experimental Drugs and Diagnostics Massachusetts General Hospital Harvard Medical School rperlis@partners.org
More informationDSM-5 Criteria: Bipolar Disorders
DSM-5 Criteria: Bipolar Disorders Box 1. Bipolar I Disorder: For a diagnosis of bipolar I disorder, it is necessary to meet the following criteria for a manic episode. The manic episode may have been preceded
More informationBipolar Disorder Michael Coudreaut, MD
Bipolar Disorder Michael Coudreaut, MD Consultation liaison psychiatry at Intermountain Medical Center; Adjuctive assistant professor, Departments of psychiaitry, University of Utah; Salt Lake City, Utah
More informationBipolar disorder, sometimes called manicdepressive
XXASIN_2_4_p151_157 10/25/04 3:45 PM Page 151 ROLE OF ANTIPSYCHOTIC MEDICATIONS IN TREATING BIPOLAR DISORDER * Mary Jane Strong, APRN, MS, CS ABSTRACT Although no cure exists for bipolar disorder, treatment
More informationEarly Intervention in Bipolar Disorder Depends on Early Identification: Strategies for Optimizing Positive Outcomes
Early Intervention in Bipolar Disorder Depends on Early Identification: Strategies for Optimizing Positive Outcomes Ellen Frank, PhD Distinguished Professor of Psychiatry, University of Pittsburgh School
More informationLong-term Treatment in Bipolar Disorder: Fall 2016 Update
Long-term Treatment in Bipolar Disorder: Fall 2016 Update Roy H. Perlis, MD MSc Center for Experimental Drugs and Diagnostics Massachusetts General Hospital Harvard Medical School rperlis@partners.org
More informationBipolar Disorder A Focus on Depression
clinical practice Bipolar Disorder A Focus on Depression Mark A. Frye, M.D. This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies
More informationSeptember 26 28, 2013 Westin Tampa Harbour Island. Co-sponsored by
September 26 28, 2013 Westin Tampa Harbour Island Co-sponsored by Best Practices in the Management of Bipolar Disorder Robert M. A. Hirschfeld, MD University of Texas Medical Branch Galveston, TX Peter
More informationMajor Depressive Disorder (MDD) in Children under Age 6
in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 6. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian
More informationAggression (Severe) in Children under Age 6
Aggression (Severe) in Children under Age 6 Level 0 Comprehensive diagnostic assessments. Refer to Principles of Practice on page 6. Evaluate and treat comorbid conditions (i.e. medical, other psychiatric
More informationBipolar Disorder Clinical Practice Guideline Summary for Primary Care
Bipolar Disorder Clinical Practice Guideline Summary for Primary Care DIAGNOSIS AND CLINICAL ASSESSMENT Bipolar Disorder is categorized by extreme mood cycling; manifested by periods of euphoria, grandiosity,
More informationPreferred Practice Guidelines Bipolar Disorder in Children and Adolescents
BadgerCare Plus Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice
More informationObjectives. DSM-V Changes: Elimination of Multiaxial Diagnostic System
Conflicts of Interest I have no conflicts to disclose. 2014 Updates to the Updates in Pharmacotherapy Webinar Psychiatry Updates for Pharmacotherapy Specialists Jacintha S. Cauffield, Pharm.D., BCPS Associate
More informationMood Disorders and Addictions: A shared biology?
Mood Disorders and Addictions: A shared biology? Dr. Paul Stokes Clinical Senior Lecturer, Centre for Affective Disorders, Department of Psychological Medicine Disclosures No relevant disclosures: No paid
More informationResubmission. Scottish Medicines Consortium
Scottish Medicines Consortium Resubmission aripiprazole 5mg, 10mg, 15mg, 0mg tablets; 10mg, 15mg orodispersible tablets; 1mg/mL oral solution (Abilify ) No. (498/08) Bristol-Myers Squibb Pharmaceuticals
More informationAny news of innovative treatment options in schizoaffective disorder?
Any news of innovative treatment options in schizoaffective disorder? Andrea Murru, MD, PhD Lisbon, 26th of April 2015 Centro de Investigación Biomédica En Red de Salud Mental Conflitti di Interesse Name
More informationThe Comparison of the Effectiveness of Thiothixene and Risperidone as a Combination with Lithium for the Treatment of Patients with Bipolar Disorder
Zahedan Journal of Research in Medical Sciences Journal homepage: www.zjrms.ir The Comparison of the Effectiveness of Thiothixene and Risperidone as a Combination with Lithium for the Treatment of Patients
More informationBipolar Disorders Expert Column Series Rapid-Cycling Bipolar Disorder: Emerging Treatments and Enduring Controversies
To Print: Click your browser's PRINT button. Bipolar Disorders Expert Column Series Rapid-Cycling Bipolar Disorder: Emerging Treatments and Enduring Controversies Joseph F. Goldberg, MD; Jinger Hoop, MD
More informationAs we have seen, bipolar disorder is a
LONG-TERM MOOD STABILIZATION: PHARMACOLOGIC TREATMENT STRATEGIES * Susan Simmons-Alling, MSN, APRN, BC ABSTRACT This article focuses primarily on the pharmacologic strategies recommended for bipolar disorder.
More informationUniversity of Groningen. Lamotrigine in bipolar depression Loos, Marcus Lambertus Maria van der
University of Groningen Lamotrigine in bipolar depression Loos, Marcus Lambertus Maria van der IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
More informationApril 2016 Prepared By: Kimberly D. Griego, PharmD, CGP
April 2016 Prepared By: Kimberly D. Griego, PharmD, CGP Bipolar disorder (BD), also referred to as manic-depression, presents with dramatic swings in a person s mood and energy level, which affects their
More informationPractical Psychopharmacology for More Complex Mental Health Presentations
MINISTRY OF CHILDREN AND YOUTH SERVICES Practical Psychopharmacology for More Complex Mental Health Presentations Part 2: Antipsychotics & Mood Stabilizers Dr. Ajit Ninan & Joel Lamoure 1 : Who are we?
More informationPharmacological aspects
Acute and long-term treatment of mania Eduard Vieta, MD, PhD; Jose Sanchez-Moreno, PsyD The treatment of mania starts with a correct diagnosis and elementary measures to prevent risks for the patient,
More informationAdherence in A Schizophrenia:
Understanding and Diagnosing Bipolar Disorder Treatment Promoting for Bipolar Treatment Disorder Adherence in A Schizophrenia: Resource for Providers Engagement Strategies for Health Care Providers, Case
More informationMood Disorders.
Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner
More informationA Critical Review of. Current Guidelines for Bipolar Disorder. R. Hamish McAllister-Williams, MD, PhD, MRCPsych
A Critical Review of Psychobiology Research Group Current Guidelines for Bipolar Disorder R. Hamish McAllister-Williams, MD, PhD, MRCPsych Reader in Clinical Psychopharmacology University of Newcastle
More informationMixing and Matching: Layering Medications as Family Physicians
Mixing and Matching: Layering Medications as Family Physicians Family Medicine Forum Vancouver, B.C. November 9-12, 2016. Jon Davine, CCFP, FRCP(C) McMaster University Objectives Discuss different examples
More informationBipolar Depression Update 2016
Bipolar Depression Update 2016 Andrew A. Nierenberg, MD Thomas P. Hackett, MD, Endowed Chair in Psychiatry Director, Bipolar Clinic and Research Program Massachusetts General Hospital Professor of Psychiatry,
More informationBipolar treatment update
Bipolar treatment update Evidence is driving change Texas Medication Algorithm Project will weigh data on atypical antipsychotics in mania and on continuing antidepressants after bipolar depression remits.
More informationBipolar disorders: treatment options and patient satisfaction
REVIEW Bipolar disorders: treatment options and patient satisfaction Charles Bowden Vivek Singh Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, TX,
More informationPharmacotherapy of Bipolar Depression: An Update
Pharmacotherapy of Bipolar Depression: An Update Michael E. Thase, MD Corresponding author Michael E. Thase, MD University of Pittsburgh Medical Center, Western Psychiatric Institute and Clinic, 3811 O
More informationNOVEL INDICATIONS: Experiences from a Study in MDD with Mixed Features (Mixed Depression)
NOVEL INDICATIONS: Experiences from a Study in MDD with Mixed Features (Mixed Depression) 11 APRIL 2013 Josephine Cucchiaro, PhD Vice President Clinical Operations & Project Management Sunovion Pharmaceuticals
More informationEfficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis
International Journal of Neuropsychopharmacology (2010), 13, 5 14. Copyright f CINP 2009 doi:10.1017/s1461145709990344 Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression:
More informationIs Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A
Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A Faculty/Presenter Disclosures Faculty: Mike Allan Salary: College
More information48 th Annual Meeting. Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5. Disclosure. Depression. Patient Case. Objectives 7/19/2014
48 th Annual Meeting Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5 Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Published in 2013 Most published treatment guidelines
More informationRoles of primary care physicians in managing bipolar disorders in adults
CPG UPDATE Roles of primary care physicians in managing bipolar disorders in adults Awaluddin A, Jali N, Bahari R, Jamil Z, Haron N on behalf of Development Group Clinical Practice Guidelines Management
More informationMajor Depressive Disorder (MDD) in Children under Age 6
in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 5. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian
More informationPsychiatry Clinical Reviews Mania Matters
Mayo School of Continuous Professional Development Psychiatry Clinical Reviews Mania Matters Mark A. Frye, MD October 6-8, 2016 Intercontinental Chicago Magnificent Mile Chicago, IL Disclosures- Mark A.
More informationEfficacy of Antimanic Treatments: Meta-analysis of Randomized, Controlled Trials
(2011) 36, 375 389 & 2011 American College of. All rights reserved 0893-133X/11 $32.00 www.neuropsychopharmacology.org Efficacy of Antimanic Treatments: Meta-analysis of Randomized, Controlled Trials Ays
More informationDSM-5 Criteria: Major Depressive Disorder
DSM-5 Criteria: Major Depressive Disorder Box 3. Major Depressive Episode: DSM-5 Diagnosis: Major Depressive Disorder Five (or more) of the following symptoms have been present during the same 2-week period
More informationPRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA
CASE #1 PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA OBJECTIVES Epidemiology Presentation in older adults Assessment Treatment
More informationBipolar Depression Update 2015
Bipolar Depression Update 2015 Andrew A. Nierenberg, MD Thomas P. Hackett, MD, Chair in Psychiatry Director, Bipolar Clinic and Research Program Massachusetts General Hospital Professor of Psychiatry,
More informationClinical Perspective on Conducting TRD Studies. Hans Eriksson, M.D., Ph.D., M.B.A. Chief Medical Specialist, H. Lundbeck A/S Valby, Denmark
Clinical Perspective on Conducting TRD Studies Hans Eriksson, M.D., Ph.D., M.B.A. Chief Medical Specialist, H. Lundbeck A/S Valby, Denmark Overview of Presentation Treatment-Resistant Depression (TRD)
More informationAPPENDIX 33: HEALTH ECONOMICS ECONOMIC EVIDENCE PROFILES
APPENDIX 33: HEALTH ECONOMICS ECONOMIC EVIDENCE PROFILES 1.1 Case identification assessment of adults with bipolar disorder... 2 1.1.1 Clinical/economic question: Mood Disorder Questionnaire (MDQ) versus
More informationTreatment Options for Bipolar Disorder Contents
Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8
More informationBipolar disorder is a lifelong debilitating PROCEEDINGS EVOLVING ROLE OF ANTIPSYCHOTIC THERAPY IN THE MANAGEMENT OF BIPOLAR DISORDER *
EVOLVING ROLE OF ANTIPSYCHOTIC THERAPY IN THE MANAGEMENT OF BIPOLAR DISORDER * Karen C. Tugrul, RN, BSN ABSTRACT The lifetime prevalence of bipolar I disorder in the United States is reported to be between
More informationAntipsychotics. Something Old, Something New, Something Used to Treat the Blues
Antipsychotics Something Old, Something New, Something Used to Treat the Blues Objectives To provide an overview of the key differences between first and second generation agents To an overview the newer
More informationPennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016
Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Disclosures: Bipolare Disorder Initial Evaliaton and Referral Criteria
More informationIs Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A
Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A Faculty/Presenter Disclosures Faculty: Mike Allan Salary: College
More informationAdult Depression - Clinical Practice Guideline
1 Adult Depression - Clinical Practice Guideline 05/2018 Diagnosis and Screening Diagnostic criteria o Please refer to Attachment A Screening o The United States Preventative Services Task Force (USPSTF)
More informationTreatments for Acute Bipolar Depression: Metaanalyses of Placebo-controlled, Monotherapy Trials of Anticonvulsants, Lithium and Antipsychotics
Review 43 Treatments for Acute Bipolar Depression: Metaanalyses of Placebo-controlled, Monotherapy Trials of Anticonvulsants, Lithium and Antipsychotics Authors V. Selle 1, 2, S. Schalkwijk 1, 3, G. H.
More informationKing s Research Portal
King s Research Portal DOI: 10.1017/S1092852917000013 Document Version Peer reviewed version Link to publication record in King's Research Portal Citation for published version (APA): Cuomo, A., Nikolova,
More informationComprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula
Comprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula Official Name Bipolar Disorder; also referred to as Manic Depression Definitions (DSM-IV-TR, 2000) Bipolar I Disorder
More informationMood Disorders in Children and Adolescents
Mood Disorders in Children and Adolescents Manpreet K. Singh, MD, MS Assistant Professor of Psychiatry and Behavioral Sciences Director, Pediatric Mood Disorders Program Akiko Yamazaki and Jerry Yang Faculty
More informationClinical Practice Guidelines for Management of Bipolar Disorder
CLINICAL PRACTICE GUIDELINES Clinical Practice Guidelines for Management of Bipolar Disorder Nilesh Shah, Sandeep Grover 1, G. Prasad Rao 2 Department of Psychiatry, L. T. M. Medical College and General
More informationIs there consensus across international evidence-based guidelines for the management of bipolar disorder?
Acta Psychiatr Scand 2017: 135: 515 526 All rights reserved DOI: 10.1111/acps.12717 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd ACTA PSYCHIATRICA SCANDINAVICA Review Is there consensus
More informationLong-term Treatment in Bipolar Disorder: Fall 2017 Update
Long-term Treatment in Bipolar Disorder: Fall 2017 Update Roy H. Perlis, MD MSc Center for Experimental Drugs and Diagnostics Massachusetts General Hospital Harvard Medical School rperlis@partners.org
More informationREXULTI (brexpiprazole) oral tablet
REXULTI (brexpiprazole) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
More informationDISEASES AND DISORDERS
DISEASES AND DISORDERS 13. The mood (affective) disorders 99 14. The psychotic disorders: schizophrenia 105 15. The anxiety and somatoform disorders 111 16. Dementia and delirium 117 17. Alcohol and substance-related
More information